The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Peripheral Blood Mononuclear Cells (PBMC) Market Research Report 2025
Synopsis
The global Peripheral Blood Mononuclear Cells (PBMC) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Peripheral Blood Mononuclear Cells (PBMC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Blood Mononuclear Cells (PBMC).
Report Scope
The Peripheral Blood Mononuclear Cells (PBMC) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peripheral Blood Mononuclear Cells (PBMC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Blood Mononuclear Cells (PBMC) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
STEMCELL Technologies
Zen-Bio
ATCC
AllCells
Segment by Type
≥ 50 Million Cells
Other
Segment by Application
ELISPOT
Proliferation Assays
Immunogenicity Assays
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peripheral Blood Mononuclear Cells (PBMC) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Peripheral Blood Mononuclear Cells (PBMC) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Peripheral Blood Mononuclear Cells (PBMC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Blood Mononuclear Cells (PBMC).
Report Scope
The Peripheral Blood Mononuclear Cells (PBMC) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peripheral Blood Mononuclear Cells (PBMC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Blood Mononuclear Cells (PBMC) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
STEMCELL Technologies
Zen-Bio
ATCC
AllCells
Segment by Type
≥ 50 Million Cells
Other
Segment by Application
ELISPOT
Proliferation Assays
Immunogenicity Assays
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peripheral Blood Mononuclear Cells (PBMC) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ≥ 50 Million Cells
1.2.3 Other
1.3 Market by Application
1.3.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 ELISPOT
1.3.3 Proliferation Assays
1.3.4 Immunogenicity Assays
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Perspective (2019-2030)
2.2 Peripheral Blood Mononuclear Cells (PBMC) Growth Trends by Region
2.2.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Peripheral Blood Mononuclear Cells (PBMC) Historic Market Size by Region (2019-2024)
2.2.3 Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Region (2025-2030)
2.3 Peripheral Blood Mononuclear Cells (PBMC) Market Dynamics
2.3.1 Peripheral Blood Mononuclear Cells (PBMC) Industry Trends
2.3.2 Peripheral Blood Mononuclear Cells (PBMC) Market Drivers
2.3.3 Peripheral Blood Mononuclear Cells (PBMC) Market Challenges
2.3.4 Peripheral Blood Mononuclear Cells (PBMC) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Blood Mononuclear Cells (PBMC) Players by Revenue
3.1.1 Global Top Peripheral Blood Mononuclear Cells (PBMC) Players by Revenue (2019-2024)
3.1.2 Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Players (2019-2024)
3.2 Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peripheral Blood Mononuclear Cells (PBMC) Revenue
3.4 Global Peripheral Blood Mononuclear Cells (PBMC) Market Concentration Ratio
3.4.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Blood Mononuclear Cells (PBMC) Revenue in 2023
3.5 Peripheral Blood Mononuclear Cells (PBMC) Key Players Head office and Area Served
3.6 Key Players Peripheral Blood Mononuclear Cells (PBMC) Product Solution and Service
3.7 Date of Enter into Peripheral Blood Mononuclear Cells (PBMC) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Blood Mononuclear Cells (PBMC) Breakdown Data by Type
4.1 Global Peripheral Blood Mononuclear Cells (PBMC) Historic Market Size by Type (2019-2024)
4.2 Global Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Type (2025-2030)
5 Peripheral Blood Mononuclear Cells (PBMC) Breakdown Data by Application
5.1 Global Peripheral Blood Mononuclear Cells (PBMC) Historic Market Size by Application (2019-2024)
5.2 Global Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size (2019-2030)
6.2 North America Peripheral Blood Mononuclear Cells (PBMC) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2019-2024)
6.4 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size (2019-2030)
7.2 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2019-2024)
7.4 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size (2019-2030)
8.2 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (2019-2024)
8.4 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size (2019-2030)
9.2 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2019-2024)
9.4 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size (2019-2030)
10.2 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2019-2024)
10.4 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.1.4 Lonza Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 STEMCELL Technologies
11.2.1 STEMCELL Technologies Company Detail
11.2.2 STEMCELL Technologies Business Overview
11.2.3 STEMCELL Technologies Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.2.4 STEMCELL Technologies Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2019-2024)
11.2.5 STEMCELL Technologies Recent Development
11.3 Zen-Bio
11.3.1 Zen-Bio Company Detail
11.3.2 Zen-Bio Business Overview
11.3.3 Zen-Bio Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.3.4 Zen-Bio Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2019-2024)
11.3.5 Zen-Bio Recent Development
11.4 ATCC
11.4.1 ATCC Company Detail
11.4.2 ATCC Business Overview
11.4.3 ATCC Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.4.4 ATCC Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2019-2024)
11.4.5 ATCC Recent Development
11.5 AllCells
11.5.1 AllCells Company Detail
11.5.2 AllCells Business Overview
11.5.3 AllCells Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.5.4 AllCells Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2019-2024)
11.5.5 AllCells Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of ≥ 50 Million Cells
Table 3. Key Players of Other
Table 4. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Region (2019-2024)
Table 8. Global Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Region (2025-2030)
Table 10. Peripheral Blood Mononuclear Cells (PBMC) Market Trends
Table 11. Peripheral Blood Mononuclear Cells (PBMC) Market Drivers
Table 12. Peripheral Blood Mononuclear Cells (PBMC) Market Challenges
Table 13. Peripheral Blood Mononuclear Cells (PBMC) Market Restraints
Table 14. Global Peripheral Blood Mononuclear Cells (PBMC) Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Players (2019-2024)
Table 16. Global Top Peripheral Blood Mononuclear Cells (PBMC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Blood Mononuclear Cells (PBMC) as of 2023)
Table 17. Ranking of Global Top Peripheral Blood Mononuclear Cells (PBMC) Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Peripheral Blood Mononuclear Cells (PBMC) Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Peripheral Blood Mononuclear Cells (PBMC) Product Solution and Service
Table 21. Date of Enter into Peripheral Blood Mononuclear Cells (PBMC) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Type (2019-2024)
Table 25. Global Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Type (2025-2030)
Table 27. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Application (2019-2024)
Table 29. Global Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Application (2025-2030)
Table 31. North America Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2025-2030) & (US$ Million)
Table 46. Lonza Company Detail
Table 47. Lonza Business Overview
Table 48. Lonza Peripheral Blood Mononuclear Cells (PBMC) Product
Table 49. Lonza Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2019-2024) & (US$ Million)
Table 50. Lonza Recent Development
Table 51. STEMCELL Technologies Company Detail
Table 52. STEMCELL Technologies Business Overview
Table 53. STEMCELL Technologies Peripheral Blood Mononuclear Cells (PBMC) Product
Table 54. STEMCELL Technologies Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2019-2024) & (US$ Million)
Table 55. STEMCELL Technologies Recent Development
Table 56. Zen-Bio Company Detail
Table 57. Zen-Bio Business Overview
Table 58. Zen-Bio Peripheral Blood Mononuclear Cells (PBMC) Product
Table 59. Zen-Bio Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2019-2024) & (US$ Million)
Table 60. Zen-Bio Recent Development
Table 61. ATCC Company Detail
Table 62. ATCC Business Overview
Table 63. ATCC Peripheral Blood Mononuclear Cells (PBMC) Product
Table 64. ATCC Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2019-2024) & (US$ Million)
Table 65. ATCC Recent Development
Table 66. AllCells Company Detail
Table 67. AllCells Business Overview
Table 68. AllCells Peripheral Blood Mononuclear Cells (PBMC) Product
Table 69. AllCells Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2019-2024) & (US$ Million)
Table 70. AllCells Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Type: 2023 VS 2030
Figure 3. ≥ 50 Million Cells Features
Figure 4. Other Features
Figure 5. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Application: 2023 VS 2030
Figure 7. ELISPOT Case Studies
Figure 8. Proliferation Assays Case Studies
Figure 9. Immunogenicity Assays Case Studies
Figure 10. Other Case Studies
Figure 11. Peripheral Blood Mononuclear Cells (PBMC) Report Years Considered
Figure 12. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Region: 2023 VS 2030
Figure 15. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Players in 2023
Figure 16. Global Top Peripheral Blood Mononuclear Cells (PBMC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Blood Mononuclear Cells (PBMC) as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Peripheral Blood Mononuclear Cells (PBMC) Revenue in 2023
Figure 18. North America Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Peripheral Blood Mononuclear Cells (PBMC) Market Share by Country (2019-2030)
Figure 20. United States Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Share by Country (2019-2030)
Figure 24. Germany Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Share by Region (2019-2030)
Figure 32. China Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Share by Country (2019-2030)
Figure 40. Mexico Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Share by Country (2019-2030)
Figure 44. Turkey Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Lonza Revenue Growth Rate in Peripheral Blood Mononuclear Cells (PBMC) Business (2019-2024)
Figure 47. STEMCELL Technologies Revenue Growth Rate in Peripheral Blood Mononuclear Cells (PBMC) Business (2019-2024)
Figure 48. Zen-Bio Revenue Growth Rate in Peripheral Blood Mononuclear Cells (PBMC) Business (2019-2024)
Figure 49. ATCC Revenue Growth Rate in Peripheral Blood Mononuclear Cells (PBMC) Business (2019-2024)
Figure 50. AllCells Revenue Growth Rate in Peripheral Blood Mononuclear Cells (PBMC) Business (2019-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
